|
|
Post by itellthefuture777 on Jul 19, 2021 23:40:41 GMT -5
|
|
|
|
Post by brentie on Dec 6, 2021 7:09:21 GMT -5
|
|
|
|
Post by boca1girl on Dec 13, 2021 13:00:57 GMT -5
Latham Partners conference 12/13/21
I listened to the presentation today and my main take away is that there won’t be any news to move the stock price before year end.
- UT hasn’t resubmitted to the FDA yet
- No news from RLS expected before EOY
- Pipeline Updates are expected 1Q-2Q 2022
Overall positive presentation for 2022-2023 but I don’t expect much sp movement near term. I will listen to the replay tonight.
|
|
|
|
Post by markado on Dec 13, 2021 16:46:45 GMT -5
Latham Partners conference 12/13/21 I listened to the presentation today and my main take away is that there won’t be any news to move the stock price before year end. - UT hasn’t resubmitted to the FDA yet - No news from RLS expected before EOY - Pipeline Updates are expected 1Q-2Q 2022 Overall positive presentation for 2022-2023 but I don’t expect much sp movement near term. I will listen to the replay tonight. Did they touch on status of enrollment for the peds trial? It'd be nice if that were on track or slightly ahead of schedule. |
|
